Attenuation of gentamicin-induced nephrotoxicity in rats by fleroxacin

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1237-1245

  Beauchamp, Denis ^a,b   Laurent, Guy ^c   Grenier, Louis ^a,b   Gourde, Pierrette ^a,b   Zanen, Jacqueline ^c   Heuson Stiennon, Jeanine Anne ^c   Bergeron, Michel G ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF MONS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLEROXACIN; GENTAMICIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFECT; DRUG HALF LIFE; ENDOCYTOSIS; ENZYME ACTIVITY; EXOCYTOSIS; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY TUBULE NECROSIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030957328     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1237     Document Type: Article

References (42)

1. Andriole, V. T. 1994. Fleroxacin: the newly introduced once-daily quinolone. Int. J. Antimicrob. Agents 4(Suppl. 2):S1-S6.
2. Aoyama, H., M. Inoue, and S. Mitsuhashi. 1988. In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone. J. Antimicrob. Chemother. 22(Suppl. D):99-114.
3. Barrett, J. F., T. D. Gootz, P. R. McGuirk, C. A. Farrell, and S. A. Sokolowski. 1989. Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents. Antimicrob. Agents Chemother. 33:1697-1703.
4. Beauchamp, D., G. Laurent, P. Maldague, S. Abid, B. K. Kishore, and P. M. Tulkens. 1990. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. J. Pharmacol. Exp. Ther. 255:858-866.
5. Beauchamp, D., G. Thériault, L. Grenier, P. Gourde, S. Perron, Y. Bergeron, L. Fontaine, and M. G. Bergeron. 1994. Ceftriaxone protects against tobramycin nephrotoxicity. Antimicrob. Agents Chemother. 38:750-756.
6. Beauchamp, D., M. Pellerin, P. Gourde, M. Pettigrew, and M. G. Bergeron. 1990. Effects of daptomycin and vancomycin on tobramycin nephrotoxicity in rats. Antimicrob. Agents Chemother. 34:139-147.
7. Beauchamp, D., P. Gourde, and M. G. Bergeron. 1991. Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling. Antimicrob. Agents Chemother. 35:2173-2179.
8. Bergeron, M. G. 1989. The pharmacokinetics and tissue penetration of the fluoroquinolones. Clin. Invest. Med. 12:20-27.
9. Bloch, R., F. C. Luft, L. I. Rankin, R. S. Sloan, M. N. Yum, and D. R. Maxwell. 1979. Protection from gentamicin nephrotoxicity by cephalotin and carbenicillin. Antimicrob. Agents Chemother. 15:46-49.
10. Christ, W., T. Lehnert, and B. Ulbrich. 1991. Specific toxicologic aspects of the quinolones. Rev. Infect. Dis. 10(Suppl. 1):S141-S146.
11. Couture, M., M. Simard, P. Gourde, C. Lessard, K. Gurnani, L. Lin, D. Carrier, M. G. Bergeron, and D. Beauchamp. 1994. Daptomycin may attenuate experimental tobramycin nephrotoxicity by electrostatic complexation to tobramycin. Antimicrob. Agents Chemother. 38:742-749.
12. English, J., D. N. Gilbert, S. Koelhepp, P. W. Koehnen, G. Mayor, D. C. Houghton, and W. M. Bennett. 1985. Attenuation of an experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob. Agents Chemother. 27:897-902.
13. Felmingham, D., M. J. Robbins, M. D. O'Hare, K. Jones, G. Ridgway, and R. N. Gruneberg. 1989. In vitro activity and synergy studies with fleroxacin, p. 162-164. In G. Nicolletti and G. Cocuzza (ed.), Proceedings of the Sixth Mediterranean Congress of Chemotherapy, Taormina, Italy.
14. 18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography. Antimicrob. Agents Chemother. 40:659-664.
15. 18F]fleroxacin in healthy human subjects by using positron emission tomography. Antimicrob. Agents Chemother. 37:2144-2152.
16. 18F]fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography. Antimicrob. Agents Chemother. 36:2286-2292.
17. Gilbert, D. N., C. A. Wood, S. J. Koehlepp, P. W. Koehnen, D. C. Houghton, H. C. Finkbeiner, J. Lindsley, and W. E. Bennett. 1989. Poly-aspartic acid prevents experimental aminoglycoside nephrotoxicity. J. Infect. Dis. 159: 945-953.
18. Giuliano, R. A., G. J. Paulus, G. A. Verpooten, V. Pattyn, D. E. Pollet, P. M. Tulkens, and M. E. de Broe. 1984. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int. 26:838-847.
19. Giurgea-Marion, L., G. Toubeau, G. Laurent, J. A. Heuson-Stiennon, and P. M. Tulkens. 1986. Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol. Appl. Pharmacol. 86:271-285.
20. Haller, I. 1985. Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains. Antimicrob. Agents Chemother. 28:663-666.
21. Hoshino, K., K. Sato, T. Une, and Y. Osada. 1989. Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus. Antimicrob. Agents Chemother. 33:1816-1818.
22. Hussy, P., G. Maass, B. Tümmler, F. Grosse, and U. Schomberg. 1986. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase α primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob. Agents Chemother. 29:1073-1078.
23. Kojima, R., M. Ito, and Y. Suzuki. 1986. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from those effects. 3. Protective effect of latamoxef against tobramycin induced nephrotoxicity and its protective mechanism. Jpn. J. Pharmacol. 42:397-404.
24. Kusajima, H., N. Ishikawa, M. Machida, H. Uchida, and T. Irikura. 1986. Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys. Antimicrob. Agents Chemother. 30:304-309.
25. Laurent, G., M. B. Carlier, B. Rollmann, F. Van Hoff, and P. M. Tulkens. 1982. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem. Pharmacol. 31:3861-3870.
26. Laurent, G., P. Maldague, M. B. Carlier, and P. M. Tulkens. 1983. Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob. Agents Chemother. 24:586-593.
27. Luft, F. C., L. I. Rankin, R. S. Sloan, and M. N. Yum. 1978. Recovery from aminoglycoside nephrotoxicity with continued drug administration. Antimicrob. Agents Chemother. 14:284-287.
28. Maruhn, D. 1976. Rapid colorimetric assay of β-galactosidase and N-acetyl-β-glucosaminidase in human urine. Clin. Chim. Acta 73:453-461.
29. Melcion, C., and A. Cordier. 1986. Absence of genotoxicity of quinolones to mammalian cells, p. 148. In International Symposium on New Quinolones, Geneva, Switzerland. (Abstract.)
30. Neu, H. C. 1991. Synergy and antagonism of combination with quinolones. Eur. J. Clin. Microbiol. Infect. Dis. 10:255-261.
31. Neu, H. C., and N. X. Chin. 1993. In vitro activity of fleroxacin in combination with other antimicrobial agents. Am. J. Med. 94(Suppl. 3A):9S-16S.
32. Nightingale, C. H. 1993. Overview of the pharmacokinetics of fleroxacin. Am. J. Med. 94(Suppl. 3A):38S-43S.
33. Nonclercq, D., S. Wrona, G. Toubeau, J. Zanen, J. A. Heuson-Stiennon, R. P. Schaudies, and G. Laurent. 1992. Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study. Renal Fail. 14:507-521.
34. Patterson, D. R. 1991. Quinolone toxicity: methods of assessment. Am. J. Med. 91(Suppl. 6A):35S-37S.
35. Persijn, J. P., and W. van der Slik. 1976. A new method for the determination of γ-glutamyltransferase in serum. J. Clin. Chem. Clin. Biochem. 14: 421-427.
36. Rohner, P., C. Herter, R. Auckenthaler, J. C. Pechere, F. A. Waldvogel, and D. P. Lew. 1989. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species. Antimicrob. Agents Chemother. 33:2037-2041.
37. Schlüter, G. 1987. Ciprofloxacin: review of potential toxicologic effects. Am. J. Med. 82(Suppl. 4A):91S-93S.
38. Silverblatt, F. J., and C. Kuehn. 1979. Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int. 15:335-345.
39. Stuck, A. E., D. K. Kim, and F. J. Frey. 1992. Fleroxacin clinical pharmacokinetics. Clin. Pharmacokinet. 22:116-131.
40. Thibault, N., L. Grenier, M. Simard, M. G. Bergeron, and D. Beauchamp. 1994. Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity. Antimicrob. Agents Chemother. 38:1027-1035.
41. Toubeau, G., D. Nonclercq, J. Zanen, P. Lambricht, P. M. Tulkens, J. A. Heuson-Stiennon, and G. Laurent. 1991. Distribution of epidermal growth factor in the kidneys of rats exposed to amikacin. Kidney Int. 40:691-699.
42. Wood, C. A., H. C. Finkbeiner, S. J. Kohlhepp, P. W. Kohnen, and D. N. Gilbert. 1989. Influence of daptomycin on staphylococcal abscesses and experimental tobramycin nephrotoxicity. Antimicrob. Agents Chemother. 33:1280-1285.